Imunon, Inc. (IMNN) › Operating IncomeImunon, Inc. (IMNN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$19.64M2011: -$23.02M2012: -$22.14M2013: -$15.41M2014: -$24.72M2015: -$20.85M2016: -$20.65M2017: -$18.47M2018: -$21.07M2019: -$20.57M2020: -$18.49M2021: -$21.01M2022: -$24.92M2023: -$21.03M2024: -$19.13M2025: -$14.65M-$14.65M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$14.65M+23.4%2024-$19.13M+9.0%2023-$21.03M+15.6%2022-$24.92M-18.6%2021-$21.01M-13.6%2020-$18.49M+10.1%2019-$20.57M+2.4%2018-$21.07M-14.1%2017-$18.47M+10.6%2016-$20.65M+0.9%2015-$20.85M+15.7%2014-$24.72M-60.4%2013-$15.41M+30.4%2012-$22.14M+3.8%2011-$23.02M-17.2%2010-$19.64M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share